These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8112728)

  • 21. Assessment of the methods for the detection of Epstein-Barr virus nucleic acids and related gene products in Hodgkin's disease.
    Brousset P; Meggetto F; Chittal S; Bibeau F; Arnaud J; Rubin B; Delsol G
    Lab Invest; 1993 Oct; 69(4):483-90. PubMed ID: 8231115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells.
    Sugiura M; Imai S; Tokunaga M; Koizumi S; Uchizawa M; Okamoto K; Osato T
    Br J Cancer; 1996 Aug; 74(4):625-31. PubMed ID: 8761381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of in situ hybridization using different nonisotopic probes for detection of Epstein-Barr virus in nasopharyngeal carcinoma and immunohistochemical correlation with anti-latent membrane protein antibody.
    Brousset P; Butet V; Chittal S; Selves J; Delsol G
    Lab Invest; 1992 Oct; 67(4):457-64. PubMed ID: 1331609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of Epstein-Barr virus in Langerhans' cell histiocytosis.
    Shimakage M; Sasagawa T; Kimura M; Shimakage T; Seto S; Kodama K; Sakamoto H
    Hum Pathol; 2004 Jul; 35(7):862-8. PubMed ID: 15257550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphomas of the oral soft tissues are not preferentially associated with latent or replicative Epstein-Barr virus.
    Gulley ML; Sargeant KP; Grider DJ; Eagan PA; Davey DD; Damm DD; Robinson RA; Vandersteen DP; McGuff HS; Banks PM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Oct; 80(4):425-31. PubMed ID: 8521106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epstein-Barr virus (EBV) infection in B-cell non-Hodgkin's lymphomas in children: virus latency and its correlation with CD21 and CD23 molecules.
    Kasprzak A; Spachacz R; Wachowiak J; Stefanska K; Zabel M
    Folia Histochem Cytobiol; 2007; 45(3):169-79. PubMed ID: 17951165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of Epstein-Barr virus in AIDS-related lymphoma specimens.
    Samoszuk M; Nguyen V; Shadan FF; Ramzi E
    J Acquir Immune Defic Syndr (1988); 1993 Aug; 6(8):913-8. PubMed ID: 8391077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of Epstein-Barr virus in cutaneous T-cell lymphoma including mycosis fungoides.
    Shimakage M; Sasagawa T; Kawahara K; Yutsudo M; Kusuoka H; Kozuka T
    Int J Cancer; 2001 Apr; 92(2):226-31. PubMed ID: 11291050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) target proteins by proteome analysis: activation of EBNA2 in conditionally immortalized B cells reflects early events after infection of primary B cells by EBV.
    Schlee M; Krug T; Gires O; Zeidler R; Hammerschmidt W; Mailhammer R; Laux G; Sauer G; Lovric J; Bornkamm GW
    J Virol; 2004 Apr; 78(8):3941-52. PubMed ID: 15047810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus (EBV)-infected cells were frequently but dispersely detected in T-cell lymphomas of various types by in situ hybridization with an RNA probe specific to EBV-specific nuclear antigen 1.
    Yamamoto T; Nakamura Y; Kishimoto K; Takeuchi H; Shirakata M; Mitsuya T; Hirai K
    Virus Res; 1999 Dec; 65(1):43-55. PubMed ID: 10564752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defective expression of CD23 and autocrine growth-stimulation in Epstein-Barr virus (EBV)-transformed B cells from patients with Wiskott-Aldrich syndrome (WAS).
    Simon HU; Higgins EA; Demetriou M; Datti A; Siminovitch KA; Dennis JW
    Clin Exp Immunol; 1993 Jan; 91(1):43-9. PubMed ID: 8380367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression of Epstein-Barr virus genes in EBV-associated gastric carcinoma].
    Wang Y; Luo B; Zhao P; Huang BH
    Ai Zheng; 2004 Jul; 23(7):782-7. PubMed ID: 15248912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of c-fgr proto-oncogene expression in Epstein-Barr virus infected B-cell lines.
    Patel M; Leevers SJ; Brickell PM
    Int J Cancer; 1990 Feb; 45(2):342-6. PubMed ID: 2154410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinct clonotypic Epstein-Barr virus-induced fatal lymphoproliferative disorder in a patient with Wiskott-Aldrich syndrome.
    Nakanishi M; Kikuta H; Tomizawa K; Kojima K; Ishizaka A; Okano M; Sakiyama Y; Matsumoto S
    Cancer; 1993 Aug; 72(4):1376-81. PubMed ID: 8393374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary nasopharyngeal non-Hodgkin lymphoma and its relationship with Epstein-Barr virus infection.
    Zhang B; Zong Y; He J; Zhong B; Lin S
    Chin Med J (Engl); 2003 Jun; 116(6):913-7. PubMed ID: 12877806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1.
    Polack A; Hörtnagel K; Pajic A; Christoph B; Baier B; Falk M; Mautner J; Geltinger C; Bornkamm GW; Kempkes B
    Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10411-6. PubMed ID: 8816814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunophenotypic and genotypic analysis of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. Correlation with histologic features in 36 cases. French Study Group of Pathology for HIV-Associated Tumors.
    Raphael MM; Audouin J; Lamine M; Delecluse HJ; Vuillaume M; Lenoir GM; Gisselbrecht C; Lennert K; Diebold J
    Am J Clin Pathol; 1994 Jun; 101(6):773-82. PubMed ID: 8209868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Follicular large cell lymphoma with immunoblastic features in a child with Wiskott-Aldrich syndrome: an unusual immunodeficiency-related neoplasm not associated with Epstein-Barr virus.
    Kroft SH; Finn WG; Singleton TP; Ross CW; Sheldon S; Schnitzer B
    Am J Clin Pathol; 1998 Jul; 110(1):95-9. PubMed ID: 9661927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of Epstein-Barr virus-induced growth proliferation by a nuclear antigen EBNA2-TAT peptide.
    Farrell CJ; Lee JM; Shin EC; Cebrat M; Cole PA; Hayward SD
    Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4625-30. PubMed ID: 15070768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.